About Pivot Pharmaceuticals (OTCMKTS:PVOTF)
Pivot Pharmaceuticals Inc., formerly Neurokine Pharmaceuticals Inc., is a development-stage biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic pharmaceutical products. The Company is in the business of developing and commercializing new uses for existing prescription drugs, as well as developing encapsulation technology in the treatment of neurodegenerative diseases. The Company's research and development activities are focused on advancing drug candidates for the treatment of women's cancers, including, but not limited to metastatic endometrial cancer and triple-negative breast cancer; leveraging drug delivery treatment options to allow targeted delivery of drugs to address women's health needs in urological and/or gynecological indications, and opportunistically in-licensing later-stage drug candidates to augment its drug pipeline.
Industry, Sector and Symbol
Trailing P/E Ratio0.221879815100154
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Book Value($0.02) per share
Price / Book-72.00
Return on EquityN/A
Return on Assets745.36%
Pivot Pharmaceuticals (OTCMKTS:PVOTF) Frequently Asked Questions
What is Pivot Pharmaceuticals' stock symbol?
Pivot Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PVOTF."
When will Pivot Pharmaceuticals make its next earnings announcement?
Who are some of Pivot Pharmaceuticals' key competitors?
Some companies that are related to Pivot Pharmaceuticals include Chimerix (CMRX), Tocagen (TOCA), Newron Pharma (NWPHF), vTv Therapeutics (VTVT), Foamix Pharmaceuticals (FOMX), Orthopediatrics (KIDS), Aceto (ACET), Sientra (SIEN), MDXHealth (MXDHF), Zafgen (ZFGN), XOMA (XOMA), Kamada (KMDA), Vital Therapies (VTL), Nabriva Therapeutics (NBRV), Minerva Neurosciences (NERV), Arsanis (ASNS), Selecta Biosciences (SELB) and Veracyte (VCYT).
Who are Pivot Pharmaceuticals' key executives?
Pivot Pharmaceuticals' management team includes the folowing people:
- Ahmad Doroudian Ph.D., Chairman of the Board
- Patrick Frankham Ph.D., Interim Chief Executive Officer, Vice President - Business Development, Director
- Moira Ong, Chief Financial Officer
- Wolfgang Renz Ph.D., Director
How do I buy Pivot Pharmaceuticals stock?
Shares of Pivot Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Pivot Pharmaceuticals' stock price today?
One share of Pivot Pharmaceuticals stock can currently be purchased for approximately $1.44.
How big of a company is Pivot Pharmaceuticals?
Pivot Pharmaceuticals has a market capitalization of $118.40 million. The company earns $-6,270,000.00 in net income (profit) each year or $6.49 on an earnings per share basis.
How can I contact Pivot Pharmaceuticals?
Pivot Pharmaceuticals' mailing address is 1275 6th Ave W, VANCOUVER, BC V6H 1A6, Canada. The company can be reached via phone at +1-604-8057783.
MarketBeat Community Rating for Pivot Pharmaceuticals (PVOTF)MarketBeat's community ratings are surveys of what our community members think about Pivot Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Pivot Pharmaceuticals (OTCMKTS:PVOTF) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Pivot Pharmaceuticals (OTCMKTS:PVOTF) Earnings History and Estimates Chart
Pivot Pharmaceuticals (OTCMKTS PVOTF) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/27/2018|| || || || || || || || |
Pivot Pharmaceuticals (OTCMKTS:PVOTF) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Pivot Pharmaceuticals (OTCMKTS:PVOTF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Pivot Pharmaceuticals (OTCMKTS PVOTF)
No insider trades for this company have been tracked by MarketBeat.com
Pivot Pharmaceuticals (OTCMKTS PVOTF) News Headlines
Pivot Pharmaceuticals (OTCMKTS:PVOTF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Pivot Pharmaceuticals (OTCMKTS PVOTF) Stock Chart for Friday, February, 23, 2018